Sep 30, 2011 by Dave WilliamsonThis Week in Health CareWhere no pharma news falls through the cracks.
Sep 2, 2011 by Dave WilliamsonWhen a Good Idea Goes BadAnd with it go AstraZeneca's hopes of differentiation in a generic world.
Aug 27, 2011 by Dave WilliamsonDon't Miss This Coming TrendThe market for lightweight auto materials will double in five years.
Aug 20, 2011 by Dave WilliamsonWant Every NFL Game? No Problem!NFL Sunday Ticket is now available on PlayStation 3.
Aug 12, 2011 by Dave WilliamsonWhat Happened to U.S. Pharma?How did the domestic pharmaceutical industry fare in the most recent quarter?
Aug 12, 2011 by Dave WilliamsonDoes "FDA" Stand for "Faster Drug Approvals"?Approvals for 2011 just surpassed 2010.
Jul 13, 2011 by Dave WilliamsonRoundtable: The Biggest Risks in BiotechThree biotech companies to steer clear of.
Jul 13, 2011 by Dave WilliamsonRoundtable: Best Dividends in Health CareHunting for more income? Look here.
Jul 1, 2011 by Dave WilliamsonDentsply Acquisition Delivers SmilesThis smart deal makes money right off the bat.
Jun 30, 2011 by Dave WilliamsonPharmacy Benefits Delivering DramaCVS claims another Medco client and one messy split.
May 31, 2011 by Dave WilliamsonErie Indemnity: Dividend Dynamo or Blowup?Let's take a look at the numbers.
May 31, 2011 by Dave WilliamsonRoundtable: The World's Best BiotechsFools chime in on the best in the biotech space.
May 27, 2011 by Dave WilliamsonTimothy Geithner on Jobs, Debt, Taxes, Bailouts, and MoreTreasury Secretary shares his thoughts.
May 27, 2011 by Dave WilliamsonTimothy Geithner on Jobs, Debt, Taxes, Bailouts, and More! (Extended Edition)The Treasury Secretary shares his thoughts.
May 25, 2011 by Dave WilliamsonPay Attention to ShireThe ADHD medicine maker is busy making big moves.
Apr 29, 2011 by Dave WilliamsonJohnson & Johnson's Traumatic PurchaseJohnson & Johnson agrees to purchase trauma and spine specialist Synthes.
